HHLR ADVISORS, LTD. - Q4 2020 holdings

$12.6 Billion is the total value of HHLR ADVISORS, LTD.'s 95 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 36.0% .

 Value Shares↓ Weighting
PDD BuyPINDUODUO INCsponsored ads$1,817,570,000
+140.2%
10,230,032
+0.2%
14.45%
+152.0%
BGNE  BEIGENE LTDsponsored adr$1,413,977,000
-9.8%
5,472,2590.0%11.24%
-5.3%
JD SellJD.COM INCspon adr cl a$1,194,125,000
-3.9%
13,585,041
-15.1%
9.49%
+0.9%
ZM SellZOOM VIDEO COMMUNICATIONS INcl a$1,005,640,000
-57.3%
2,981,265
-40.5%
8.00%
-55.2%
IQ SellIQIYI INCsponsored ads$675,575,000
-23.9%
38,648,477
-1.7%
5.37%
-20.1%
UBER SellUBER TECHNOLOGIES INC$596,627,000
-15.1%
11,698,570
-39.3%
4.74%
-10.9%
ESGR  ENSTAR GROUP LIMITED$358,115,000
+26.9%
1,747,8400.0%2.85%
+33.2%
CBPO  CHINA BIOLOGIC PRODS HLDGS I$349,851,000
+6.3%
2,962,0760.0%2.78%
+11.5%
BILI  BILIBILI INCspons ads rep z$345,883,000
+106.1%
4,035,0350.0%2.75%
+116.4%
BBIO  BRIDGEBIO PHARMA INC$335,042,000
+89.5%
4,711,6040.0%2.66%
+99.0%
BEKE  KE HLDGS INCsponsored ads$307,700,000
+0.4%
5,000,0000.0%2.45%
+5.3%
GDS  GDS HLDGS LTDsponsored ads$294,369,000
+14.4%
3,143,6230.0%2.34%
+20.1%
TAL SellTAL EDUCATION GROUPsponsored ads$290,025,000
-7.4%
4,055,722
-1.5%
2.31%
-2.8%
APLS  APELLIS PHARMACEUTICALS INC$287,618,000
+89.6%
5,028,2890.0%2.29%
+99.0%
BEAM  BEAM THERAPEUTICS INC$242,177,000
+231.6%
2,966,4030.0%1.92%
+248.1%
CRM BuySALESFORCE COM INC$238,573,000
-3.9%
1,072,095
+8.5%
1.90%
+0.9%
KOD NewKODIAK SCIENCES INC$170,035,0001,157,407
+100.0%
1.35%
FGEN  FIBROGEN INC$146,720,000
-9.8%
3,955,7870.0%1.17%
-5.4%
BPMC SellBLUEPRINT MEDICINES CORP$142,490,000
+12.6%
1,270,529
-6.9%
1.13%
+18.3%
ARGX  ARGENX SEsponsored adr$138,222,000
+12.0%
470,0000.0%1.10%
+17.5%
DASH NewDOORDASH INCcl a$122,551,000858,500
+100.0%
0.97%
MDLZ SellMONDELEZ INTL INCcl a$120,201,000
-6.0%
2,055,764
-7.6%
0.96%
-1.2%
ZTO  ZTO EXPRESS CAYMAN INCsponsored ads a$97,554,000
-2.5%
3,345,4750.0%0.78%
+2.4%
ALGN SellALIGN TECHNOLOGY INC$97,408,000
-24.7%
182,283
-53.9%
0.77%
-21.0%
SNOW SellSNOWFLAKE INCcl a$94,550,000
-10.3%
336,000
-20.0%
0.75%
-5.9%
VIE SellVIELA BIO INC$85,695,000
+23.2%
2,382,414
-3.8%
0.68%
+29.2%
GOSS  GOSSAMER BIO INC$71,761,000
-22.1%
7,420,9740.0%0.57%
-18.2%
IMAB  I MABsponsored ads$70,562,000
+0.3%
1,496,5400.0%0.56%
+5.3%
SE BuySEA LTDsponsord ads$67,204,000
+397.9%
337,622
+285.3%
0.53%
+423.5%
ALGS NewALIGOS THERAPEUTICS INC$59,864,0002,165,064
+100.0%
0.48%
YQ New17 ED & TECHNOLOGY GROUP INCads$59,482,0004,643,391
+100.0%
0.47%
GMAB SellGENMAB A/Ssponsored ads$57,058,000
+3.9%
1,403,288
-6.4%
0.45%
+9.1%
PRLD  PRELUDE THERAPEUTICS INC$53,663,000
+137.5%
750,0000.0%0.43%
+149.7%
KNSA  KINIKSA PHARMACEUTICALS LTD$51,597,000
+15.3%
2,920,0230.0%0.41%
+20.9%
MELI  MERCADOLIBRE INC$46,110,000
+54.8%
27,5250.0%0.37%
+62.4%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored ads$43,670,000
+34.5%
400,4950.0%0.35%
+41.1%
AKRO  AKERO THERAPEUTICS INC$42,742,000
-16.2%
1,656,6730.0%0.34%
-11.9%
OTIS  OTIS WORLDWIDE CORP$41,513,000
+8.2%
614,5560.0%0.33%
+13.4%
ROOT NewROOT INC$40,846,0002,600,000
+100.0%
0.32%
AAPL NewAPPLE INC$39,807,000300,000
+100.0%
0.32%
KDP BuyKEURIG DR PEPPER INC$39,445,000
+195.2%
1,232,666
+154.6%
0.31%
+210.9%
Z  ZILLOW GROUP INCcl c cap stk$39,243,000
+27.8%
302,3360.0%0.31%
+33.9%
FMTX BuyFORMA THERAPEUTICS HLDGS INC$38,390,000
+54.1%
1,100,000
+120.0%
0.30%
+61.4%
CALT BuyCALLIDITAS THERAPEUTICS ABsponsered ads$35,611,000
+323.9%
1,047,687
+199.3%
0.28%
+342.2%
NKTX  NKARTA INC$34,150,000
+104.5%
555,5560.0%0.27%
+114.2%
YSG NewYATSEN HLDG LTDads$34,074,0002,004,329
+100.0%
0.27%
AMG  AFFILIATED MANAGERS GROUP IN$34,077,000
+48.7%
335,0730.0%0.27%
+55.7%
MLCO  MELCO RESORTS AND ENTMNT LTDadr$31,514,000
+11.4%
1,698,8770.0%0.25%
+17.3%
OLMA NewOLEMA PHARMACEUTICALS INC$29,829,000620,397
+100.0%
0.24%
AXSM NewAXSOME THERAPEUTICS INC$29,329,000360,000
+100.0%
0.23%
HTHT BuyHUAZHU GROUP LTDsponsored ads$25,086,000
+350.5%
557,102
+332.6%
0.20%
+373.8%
ABCL NewABCELLERA BIOLOGICS INC$24,144,000600,000
+100.0%
0.19%
EIDX  EIDOS THERAPEUTICS INC$23,500,000
+160.4%
178,6000.0%0.19%
+175.0%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$22,958,000
-9.9%
3,985,7970.0%0.18%
-5.2%
MOGU  MOGU INCspon ads$22,670,000
-7.7%
10,446,9700.0%0.18%
-3.2%
KURA NewKURA ONCOLOGY INC$21,229,000650,000
+100.0%
0.17%
RGNX  REGENXBIO INC$20,684,000
+64.8%
456,0000.0%0.16%
+72.6%
ALLO  ALLOGENE THERAPEUTICS INC$20,192,000
-33.1%
800,0000.0%0.16%
-29.7%
KRON NewKRONOS BIO INC$19,667,000658,436
+100.0%
0.16%
LEGN  LEGEND BIOTECH CORPsponsored ads$18,304,000
-8.8%
650,0000.0%0.15%
-3.9%
BLI  BERKELEY LTS INC$17,882,000
+17.1%
200,0000.0%0.14%
+22.4%
ACMR BuyACM RESEARCH INC$17,394,000
+115.4%
214,079
+83.2%
0.14%
+126.2%
RCUS  ARCUS BIOSCIENCES INC$16,225,000
+51.5%
625,0000.0%0.13%
+59.3%
ADCT  ADC THERAPEUTICS SA$16,005,000
-3.0%
500,0000.0%0.13%
+1.6%
IGMS SellIGM BIOSCIENCES INC$13,366,000
-48.3%
151,390
-56.7%
0.11%
-45.9%
SOHU  SOHU COM LTDsponsored ads$12,784,000
-19.7%
802,0340.0%0.10%
-15.7%
GRUB  GRUBHUB INC$12,580,000
+2.7%
169,3860.0%0.10%
+7.5%
DYN  DYNE THERAPEUTICS INC$12,600,000
+4.0%
600,0000.0%0.10%
+8.7%
CDAK NewCODIAK BIOSCIENCES INC$11,845,000366,721
+100.0%
0.09%
COGT NewCOGENT BIOSCIENCES INC$11,230,0001,000,000
+100.0%
0.09%
RNA  AVIDITY BIOSCIENCES INC$10,846,000
-9.3%
425,0000.0%0.09%
-5.5%
MREO BuyMEREO BIOPHARMA GROUP PLCads$10,655,000
+154.5%
2,976,121
+86.2%
0.08%
+165.6%
TXG  10X GENOMICS INC$10,620,000
+13.6%
75,0000.0%0.08%
+18.3%
MRUS  MERUS N V$10,518,000
+46.1%
600,0000.0%0.08%
+52.7%
HOOK  HOOKIPA PHARMA INC$10,461,000
+17.1%
943,2540.0%0.08%
+22.1%
MNSO NewMINISO GROUP HLDG LTDsponsored adr$10,343,000391,933
+100.0%
0.08%
TCRR  TCR2 THERAPEUTICS INC$9,987,000
+52.2%
322,9030.0%0.08%
+58.0%
FDMT New4D MOLECULAR THERAPEUTICS IN$9,326,000225,000
+100.0%
0.07%
GTHX SellG1 THERAPEUTICS INC$8,540,000
-22.1%
474,716
-50.0%
0.07%
-18.1%
LPTX  LEAP THERAPEUTICS INC$8,362,000
+13.6%
3,716,2400.0%0.07%
+17.9%
NXTC  NEXTCURE INC$6,958,000
+23.9%
638,3070.0%0.06%
+27.9%
FUTU  FUTU HLDGS LTDspon ads cl a$6,863,000
+59.9%
150,0000.0%0.06%
+66.7%
AVIR NewATEA PHARMACEUTICALS INC$5,223,000125,000
+100.0%
0.04%
MAACU NewMONTES ARCHIMEDES ACQUISITIOunit 09/30/2025$5,250,000500,000
+100.0%
0.04%
CJJD  CHINA JO-JO DRUGSTORES INC$4,888,000
+4.1%
4,840,0000.0%0.04%
+8.3%
CYTK NewCYTOKINETICS INC$4,794,000230,718
+100.0%
0.04%
ATNX SellATHENEX INC$4,772,000
-45.6%
431,440
-40.5%
0.04%
-42.4%
CVET  COVETRUS INC$4,458,000
+17.8%
155,1240.0%0.04%
+20.7%
CBMG  CELLULAR BIOMEDICINE GROUP I$4,323,000
+0.2%
235,2140.0%0.03%
+3.0%
CVAC SellCUREVAC N V$4,151,000
-52.1%
51,199
-72.5%
0.03%
-50.0%
DGNRU  DRAGONEER GROWTH OPPORTUN COunit 08/18/2027$2,798,000
+14.2%
200,0000.0%0.02%
+15.8%
UXIN  UXIN LTDads$2,004,000
+0.3%
2,297,3180.0%0.02%
+6.7%
LEAPU  RIBBIT LEAP LTDunit 99/99/9999$749,000
+15.2%
50,0000.0%0.01%
+20.0%
CIH  CHINA INDEX HLDGS LTDspnsrd ads a$591,000
+35.9%
300,0000.0%0.01%
+66.7%
SFUN  FANG HLDGS LTDadr new$402,000
+16.5%
30,0000.0%0.00%0.0%
NEW ExitPUXIN LTDads$0-126,145
-100.0%
-0.01%
PASG ExitPASSAGE BIO INC$0-250,616
-100.0%
-0.02%
ARVN ExitARVINAS INC$0-312,500
-100.0%
-0.06%
KYMR ExitKYMERA THERAPEUTICS INC$0-250,000
-100.0%
-0.06%
BNR ExitBURNING ROCK BIOTECH LTDsponsored ads$0-400,000
-100.0%
-0.08%
YALA ExitYALLA GROUP LTDads$0-2,000,000
-100.0%
-0.11%
XPEV ExitXPENG INCads$0-916,518
-100.0%
-0.14%
YY ExitJOYY INC$0-239,476
-100.0%
-0.15%
LI ExitLI AUTO INCsponsored ads$0-1,670,931
-100.0%
-0.22%
NVAX ExitNOVAVAX INC$0-385,158
-100.0%
-0.32%
NIO ExitNIO INCspon ads$0-2,411,750
-100.0%
-0.39%
MYOK ExitMYOKARDIA INC$0-690,658
-100.0%
-0.71%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-4,042,123
-100.0%
-9.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings